Access Statistics for Jörg C. Mahlich

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
The Changing Nature of Pharmaceutical R&D - Opportunities for Asia? 0 0 1 150 1 1 4 567
The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan 0 1 1 307 0 1 5 1,252
Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG 0 0 0 40 0 0 3 280
Total Working Papers 0 1 2 497 1 2 12 2,099

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis 0 1 2 10 0 2 6 66
Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany 0 0 0 16 1 2 2 65
Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib 0 0 0 5 0 1 2 36
Determinants of physician's office visits and potential effects of co-payments: evidence from Austria 0 0 0 3 1 1 3 21
Economic burden of osteoporotic fractures in Austria 0 0 0 3 0 0 0 48
Erratum to: Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany 0 0 0 3 1 1 1 31
Estimation of Health-State Utility Values and Factors Driving Health-Related Quality of Life in People Living with HIV and AIDS and Receiving cART in Germany: Baseline Analysis of a Cohort Study 0 0 1 2 0 1 3 11
Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy - a Discrete Choice Experiment 0 0 0 3 0 0 0 41
Intangibles Kapital und Rentabilität in der Pharmaindustrie 0 0 0 2 0 0 0 11
Patents and performance in the Japanese pharmaceutical industry: An institution-based view 0 0 0 51 0 0 2 222
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan 0 0 0 2 0 1 3 17
Pharmaceutical regulation in Europe and its impact on corporate R&D 0 1 2 13 0 1 5 73
R&D MANAGEMENT OF JAPANESE PHARMACEUTICAL FIRMS 0 0 0 3 0 3 4 19
Returns on different types of investment in the global pharmaceutical industry 0 0 4 12 0 1 5 27
The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan 0 0 0 78 1 1 5 402
Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data 0 0 0 0 0 0 1 8
Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study 0 0 0 0 0 1 2 9
Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG 0 0 0 7 2 2 5 68
Wirtschaftspolitik für wissensintensive Branchen am Beispiel der Pharmaindustrie 0 0 0 1 0 0 0 7
Total Journal Articles 0 2 9 214 6 18 49 1,182

Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Das D-A-CH-Reformbarometer: Reformpolitik in Deutschland, Österreich und der Schweiz 1 1 1 2 1 2 2 11
Total Books 1 1 1 2 1 2 2 11

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Introduction: Korea as a Newly Advanced Economy and the Role of Technology and Innovation 0 0 0 0 0 0 0 1
Telemedicine in Japan: Challenges and Opportunities 0 0 2 2 0 3 26 106
The Technological Competencies of Korea’s Firms: A Patent Analysis 0 0 0 0 0 0 0 3
Total Chapters 0 0 2 2 0 3 26 110

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2025-03-03